From September 26, 2022 to October 11, 2022, the company has repurchased 1,046,200 shares, representing 0.24% for CNY 30.1 million. With this, the company has completed the repurchase of 1,046,200 shares, representing 0.24% for CNY 30.1 million under the buyback announced on September 26, 2022.
Guangzhou Wondfo Biotech Co.,Ltd
Equities
300482
CNE100002102
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
27.76 CNY | +0.40% | -1.87% | -7.99% |
06/05 | Wondfo Biotech's Unit Gets Emergency Use Authorization from US FDA | MT |
21/04 | Guangzhou Wondfo Biotech Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.99% | 1.79B | |
-6.16% | 12.1B | |
-2.83% | 8.24B | |
+7.95% | 5.82B | |
+29.77% | 5.58B | |
-9.12% | 4.15B | |
-59.98% | 2.68B | |
+9.11% | 2.63B | |
+17.24% | 2.03B | |
+0.97% | 1.56B |
- Stock Market
- Equities
- 300482 Stock
- News Guangzhou Wondfo Biotech Co.,Ltd
- Tranche Update on Guangzhou Wondfo Biotech Co.,Ltd's Equity Buyback Plan announced on September 26, 2022.